160 related articles for article (PubMed ID: 34174897)
1. ARHGAP10 inhibits the epithelial-mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway.
Lin LL; Yang F; Zhang DH; Hu C; Yang S; Chen XQ
Cancer Cell Int; 2021 Jun; 21(1):320. PubMed ID: 34174897
[TBL] [Abstract][Full Text] [Related]
2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
3. ARHGAP10 Inhibits the Proliferation and Metastasis of CRC Cells via Blocking the Activity of RhoA/AKT Signaling Pathway.
Liu L; Xie D; Xie H; Huang W; Zhang J; Jin W; Jiang W; Xie D
Onco Targets Ther; 2019; 12():11507-11516. PubMed ID: 31920339
[TBL] [Abstract][Full Text] [Related]
4. SMAD4 inhibits glycolysis in ovarian cancer through PI3K/AKT/HK2 signaling pathway by activating ARHGAP10.
Wu K; Gong W; Sun H; Li W; Chen L; Duan Y; Zhu J; Zhang H; Ke H
Cancer Rep (Hoboken); 2024 Jan; 7(2):e1976. PubMed ID: 38230565
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
6. Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway
Shao N; Xiao Y; Zhang J; Zhu Y; Wang S; Bao S
Front Pharmacol; 2021; 12():821567. PubMed ID: 35111070
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
8. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
Liu X; Sun L; Zhang S; Zhang S; Li W
J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
[TBL] [Abstract][Full Text] [Related]
9. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/mTOR Signaling Pathways.
Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38305308
[TBL] [Abstract][Full Text] [Related]
10. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
11. The roles of ARHGAP10 in the proliferation, migration and invasion of lung cancer cells.
Teng JP; Yang ZY; Zhu YM; Ni D; Zhu ZJ; Li XQ
Oncol Lett; 2017 Oct; 14(4):4613-4618. PubMed ID: 28943961
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
Xue F; Jia Y; Zhao J
Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
14. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
15. Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer.
Huang Z; Ma N; Xiong YL; Wang L; Li WM; Lai YY; Zhang CX; Zhang ZP; Li XF; Zhao JB
Onco Targets Ther; 2019; 12():10299-10309. PubMed ID: 31819514
[TBL] [Abstract][Full Text] [Related]
16. Gli promotes tumor progression through regulating epithelial-mesenchymal transition in non-small-cell lung cancer.
Jiang L; Huang J; Hu Y; Lu P; Luo Q; Wang L
J Cardiothorac Surg; 2020 Jan; 15(1):18. PubMed ID: 31931858
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
18. PI3K/Akt/HIF-1α signaling pathway mediates HPV-16 oncoprotein-induced expression of EMT-related transcription factors in non-small cell lung cancer cells.
Liu J; Huang B; Xiu Z; Zhou Z; Liu J; Li X; Tang X
J Cancer; 2018; 9(19):3456-3466. PubMed ID: 30310502
[No Abstract] [Full Text] [Related]
19. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
[TBL] [Abstract][Full Text] [Related]
20. Reelin Promotes Cisplatin Resistance by Induction of Epithelial-Mesenchymal Transition via p38/GSK3β/Snail Signaling in Non-Small Cell Lung Cancer.
Li JM; Yang F; Li J; Yuan WQ; Wang H; Luo YQ
Med Sci Monit; 2020 Aug; 26():e925298. PubMed ID: 32764530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
